Follow the people · Insider
Kinney Horn
Kinney Horn files insider transactions with the SEC as a chief business officer of Immunome (IMNM). We hold 2 disclosed purchases and sales filed since 19 November 2020, 2 of them in the last 90 days.
- Files forIMNM
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure6 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 February 2024 — 4 August 2026Chief Business Officer · Immunome (IMNM)13 Form 4 lines · source: SEC Form 4
- Filed 10 June 2020 — 1 February 2023Chief Business Officer · Olema Pharmaceuticals (OLMA)46 Form 4 lines · source: SEC Form 4
Everything they disclosed
59 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 50,366 shares of ImmunomeSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- exercised options over 40,250 shares of ImmunomeSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- ▼ sold on the open market 90,616 shares of ImmunomeSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- exercised options over 50,366 shares of Immunome (a derivative holding)SEC Form 46 August 2026Employee Stock Option (right to buy) · traded 4 August 2026 · filed 6 August 2026
- exercised options over 40,250 shares of Immunome (a derivative holding)SEC Form 46 August 2026Employee Stock Option (right to buy) · traded 4 August 2026 · filed 6 August 2026
- was granted 31,250 shares of ImmunomeSEC Form 427 July 2026Common Stock · traded 23 July 2026 · filed 27 July 2026
- was granted 62,500 shares of Immunome (a derivative holding)SEC Form 427 July 2026Employee Stock Option (right to buy) · traded 23 July 2026 · filed 27 July 2026
- exercised options over 1,092 shares of ImmunomeSEC Form 49 July 2026Common Stock · traded 7 July 2026 · filed 9 July 2026
- ▼ sold on the open market 1,092 shares of ImmunomeSEC Form 49 July 2026Common Stock · traded 7 July 2026 · filed 9 July 2026
- exercised options over 1,092 shares of Immunome (a derivative holding)SEC Form 49 July 2026Employee Stock Option (right to buy) · traded 7 July 2026 · filed 9 July 2026
- was granted 161,000 shares of Immunome (a derivative holding)SEC Form 431 July 2025Employee Stock Option (right to buy) · traded 29 July 2025 · filed 31 July 2025
- was granted 130,000 shares of Immunome (a derivative holding)SEC Form 413 August 2024Stock option (right to buy) · traded 9 August 2024 · filed 13 August 2024
- was granted 300,000 shares of Immunome (a derivative holding)SEC Form 421 February 2024Stock option (right to buy) · traded 20 February 2024 · filed 21 February 2024
- was granted 150,000 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 42 February 2023Stock Option (Right to Buy) · traded 1 February 2023 · filed 2 February 2023
- exercised options over 5,253 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 414 March 2022Stock Option (Right to Buy) · traded 10 March 2022 · filed 14 March 2022
- exercised options over 5,253 shares of Olema PharmaceuticalsSEC Form 414 March 2022Common Stock · traded 10 March 2022 · filed 14 March 2022
- ▼ sold on the open market 5,253 shares of Olema PharmaceuticalsSEC Form 414 March 2022Common Stock · traded 10 March 2022 · filed 14 March 2022
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 414 February 2022Stock Option (Right to Buy) · traded 10 February 2022 · filed 14 February 2022
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 414 February 2022Common Stock · traded 10 February 2022 · filed 14 February 2022
- returned to the issuer 5,251 shares of Olema PharmaceuticalsSEC Form 414 February 2022Common Stock · traded 10 February 2022 · filed 14 February 2022
- was granted 133,000 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 43 February 2022Stock Option (Right to Buy) · traded 1 February 2022 · filed 3 February 2022
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 411 January 2022Stock Option (Right to Buy) · traded 10 January 2022 · filed 11 January 2022
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 411 January 2022Common Stock · traded 10 January 2022 · filed 11 January 2022
- ▼ sold on the open market 5,251 shares of Olema PharmaceuticalsSEC Form 411 January 2022Common Stock · traded 10 January 2022 · filed 11 January 2022
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 414 December 2021Stock Option (Right to Buy) · traded 10 December 2021 · filed 14 December 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 414 December 2021Common Stock · traded 10 December 2021 · filed 14 December 2021
- ▼ sold on the open market 5,251 shares of Olema PharmaceuticalsSEC Form 414 December 2021Common Stock · traded 10 December 2021 · filed 14 December 2021
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 412 November 2021Stock Option (Right to Buy) · traded 10 November 2021 · filed 12 November 2021
- exercised options over 22,417 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 412 November 2021Stock Option (Right to Buy) · traded 10 November 2021 · filed 12 November 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 412 November 2021Common Stock · traded 10 November 2021 · filed 12 November 2021
- exercised options over 22,417 shares of Olema PharmaceuticalsSEC Form 412 November 2021Common Stock · traded 10 November 2021 · filed 12 November 2021
- ▼ sold on the open market 27,668 shares of Olema PharmaceuticalsSEC Form 412 November 2021Common Stock · traded 10 November 2021 · filed 12 November 2021
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 412 October 2021Stock Option (Right to Buy) · traded 11 October 2021 · filed 12 October 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 412 October 2021Common Stock · traded 11 October 2021 · filed 12 October 2021
- ▼ sold on the open market 2,105 shares of Olema PharmaceuticalsSEC Form 412 October 2021Common Stock · traded 11 October 2021 · filed 12 October 2021
- ▼ sold on the open market 3,146 shares of Olema PharmaceuticalsSEC Form 412 October 2021Common Stock · traded 11 October 2021 · filed 12 October 2021
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 413 September 2021Stock Option (Right to Buy) · traded 10 September 2021 · filed 13 September 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 413 September 2021Common Stock · traded 10 September 2021 · filed 13 September 2021
- ▼ sold on the open market 5,251 shares of Olema PharmaceuticalsSEC Form 413 September 2021Common Stock · traded 10 September 2021 · filed 13 September 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 411 August 2021Common Stock · traded 10 August 2021 · filed 11 August 2021
- ▼ sold on the open market 5,191 shares of Olema PharmaceuticalsSEC Form 411 August 2021Common Stock · traded 10 August 2021 · filed 11 August 2021
- ▼ sold on the open market 60 shares of Olema PharmaceuticalsSEC Form 411 August 2021Common Stock · traded 10 August 2021 · filed 11 August 2021
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 411 August 2021Stock Option (Right to Buy) · traded 10 August 2021 · filed 11 August 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 413 July 2021Common Stock · traded 12 July 2021 · filed 13 July 2021
- ▼ sold on the open market 3,859 shares of Olema PharmaceuticalsSEC Form 413 July 2021Common Stock · traded 12 July 2021 · filed 13 July 2021
- ▼ sold on the open market 1,392 shares of Olema PharmaceuticalsSEC Form 413 July 2021Common Stock · traded 12 July 2021 · filed 13 July 2021
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 413 July 2021Stock Option (Right to Buy) · traded 12 July 2021 · filed 13 July 2021
- exercised options over 5,251 shares of Olema PharmaceuticalsSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
- ▼ sold on the open market 300 shares of Olema PharmaceuticalsSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
- ▼ sold on the open market 2,164 shares of Olema PharmaceuticalsSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
- ▼ sold on the open market 2,787 shares of Olema PharmaceuticalsSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
- exercised options over 5,251 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 411 June 2021Stock Option (right to buy) · traded 10 June 2021 · filed 11 June 2021
- exercised options over 57,763 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 419 May 2021Stock Option (Right to Buy) · traded 18 May 2021 · filed 19 May 2021
- exercised options over 57,763 shares of Olema PharmaceuticalsSEC Form 419 May 2021Common Stock · traded 18 May 2021 · filed 19 May 2021
- ▼ sold on the open market 49,142 shares of Olema PharmaceuticalsSEC Form 419 May 2021Common Stock · traded 18 May 2021 · filed 19 May 2021
- ▼ sold on the open market 8,621 shares of Olema PharmaceuticalsSEC Form 419 May 2021Common Stock · traded 18 May 2021 · filed 19 May 2021
- was granted 40,000 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 416 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 16 March 2021
- was granted 252,060 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 419 November 2020Stock Option (Right to Buy) · traded 10 June 2020 · filed 19 November 2020
- was granted 89,670 shares of Olema Pharmaceuticals (a derivative holding)SEC Form 419 November 2020Stock Option (Right to Buy) · traded 18 November 2020 · filed 19 November 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.